Brown Brothers Harriman & Co’s Array Biopharma Inc ARRY Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-134	Closed	-$6K	–	1345
2019 Q2	$6K	Buy	+134	New	+$3.76K	﹤0.01%	881

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Brown Brothers Harriman & Co's ARRY Position: Q3 2019 in Review

Brown Brothers Harriman & Co sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 134 shares — an estimated $6K sold.

Brown Brothers Harriman & Co first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $6K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Brown Brothers Harriman & Co reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Brown Brothers Harriman & Co sold 134 Array Biopharma Inc shares in Q3 2019, an estimated $6K.
Brown Brothers Harriman & Co first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Brown Brothers Harriman & Co's Array Biopharma Inc position peaked at $6K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2019, filed 14 Nov 2019.